STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Healthcare Pharmaceuticals
chemistry

Mira Pharmaceuticals Approves Acquisition of SKNY, Creating $60M+ Biotech Platform

byLuca Blaumann
May 8, 2025
in Pharmaceuticals, Small-Cap
Reading Time: 2 mins read
Share on TwitterShare on LinkedIn

Board approves merger following independent valuation; SKNY to contribute $5M in cash or assets at closing

Mira Pharmaceuticals (MIRA), a clinical-stage company developing novel therapies for neurologic, neuropsychiatric, and metabolic disorders, has announced that its Board of Directors has unanimously approved the acquisition of SKNY Pharmaceuticals, Inc. The deal follows independent valuations of both companies and sets a combined enterprise value exceeding $60 million.

The strategic merger includes a $5 million contribution from SKNY to Mira in either cash or other assets, which will be transferred at closing. A filing with the U.S. Securities and Exchange Commission is underway to obtain shareholder approval.

According to independent analysis by Moore Financial Consulting, SKNY Pharmaceuticals was assigned an enterprise value of $30.5 million, based on the risk-adjusted net present value (rNPV) of its lead compound, SKNY-1. Mira itself was valued at $30 million, creating a solid foundation for a unified company with complementary pipelines and commercial potential.

“This merger brings together two pipelines, two market opportunities, and one unified strategy,” said Erez Aminov, CEO of Mira. “Our focus remains on developing first-in-class therapies that target critical and underserved health needs.”

The centerpiece of SKNY’s pipeline is SKNY-1, an investigational oral compound that modulates cannabinoid receptors CB1 and CB2, as well as monoamine oxidase B (MAO-B)—an enzyme linked to dopamine metabolism and addiction. The compound is being developed for both obesity and nicotine dependence, two global health challenges with limited treatment options.

Industry projections underscore the market potential:

  • The global weight loss drug market is expected to surpass $150 billion by 2030, with increasing demand for alternatives to injectable GLP-1 therapies (Reuters).
  • The U.S. smoking cessation market is forecast to grow from $28.11 billion in 2024 to $50.90 billion by 2030, at a CAGR of 10.4% (Grand View Research).

Dr. Angel, Mira’s Chief Scientific Advisor, emphasized the scientific rationale behind SKNY-1: “This is a uniquely designed molecule that addresses the biological complexity of both obesity and addiction. The early data are promising.”

Mira views the acquisition as a pivotal step toward building a scaled, innovation-driven platform focused on areas of urgent unmet need—backed by differentiated science and a clear commercial strategy.

You might like this article:Trump Crypto Advisor David Bailey Raises $300M for New Public Bitcoin Investment Firm

Tags: GrowthMIRAMoversNewsStock Market
Previous Post

Trump Crypto Advisor David Bailey Raises $300M for New Public Bitcoin Investment Firm

Next Post

KindlyMD and Nakamoto Merge to Launch Largest Bitcoin Treasury Initiative in Public Markets

Related Posts

ProMIS Neurosciences Soars 160% After FDA Fast Track Designation for Alzheimer’s Drug

byLiliana Vida
July 21, 2025
0

PMN310 aims to deliver a safer, next-generation treatment by targeting toxic amyloid-beta in early-stage Alzheimer’s patients Shares of ProMIS Neurosciences...

trading-chart-2

BitMine Raises $250 Million to Launch One of the Largest Public Ether Treasuries

byLuca Blaumann
June 30, 2025
0

Ethereum-focused strategy attracts top crypto investors as BitMine stock surges on bold treasury pivot BitMine Immersion Technologies (BMNR) has announced...

EXCLUSIVE: MIRA Pharmaceuticals’ Disruptive Path In Neurology And Metabolic Disorders

byLiliana Vida
June 30, 2025
0

CEO Erez Aminov on Breakthrough Drug Candidates, Strategic Acquisitions, and the Vision Behind MIRA’s Innovation-Driven Pipeline MIRA Pharmaceuticals (NASDAQ: MIRA),...

Next Post

KindlyMD and Nakamoto Merge to Launch Largest Bitcoin Treasury Initiative in Public Markets

Latest News

Hims & Hers Shares Dip Despite Strong Growth as Revenue Misses Forecast

Palantir Surges Past $1 Billion Quarterly Revenue, Lifts Guidance Amid AI Boom

Tesla Board Approves $29 Billion Alternative Compensation Plan for Elon Musk

Blade Air Mobility Sells Rideshare Business to Joby Aviation for $125 Million

Qualcomm Posts Strong Q3 Results, Fueled by Automotive and IoT Growth

Based on Your Interest

Aerospace & Defense

Palo Alto Networks Eyes $20B Deal for CyberArk

July 29, 2025
trading-chart
Ecommerece

AMD and Amazon: Two Titans Poised for Explosive Growth

July 28, 2025
Entertainment

FCC Approves $8B Paramount-Skydance Merger Amid Political Controversy

July 25, 2025

Recommended

Aerospace & Defense

FAA Keeps Boeing 737 MAX Production Cap in Place Amid Ongoing Oversight

July 24, 2025
Large-Cap

Intel Beats on Revenue, Misses on Earnings; Cuts Workforce by 15%

July 24, 2025
Brokerages

Accelerant Soars in NYSE Debut, Valued at $6.4 Billion

July 24, 2025
Distributor

GoPro and Krispy Kreme Surge as Meme Stock Frenzy Reignites

July 23, 2025
Electrical Equipment

GE Vernova Soars to Record High on Raised Cash Flow Outlook

July 23, 2025
Stoxpo

Follow us on social media:

Highlights

  • Hims & Hers Shares Dip Despite Strong Growth as Revenue Misses Forecast
  • Palantir Surges Past $1 Billion Quarterly Revenue, Lifts Guidance Amid AI Boom
  • Tesla Board Approves $29 Billion Alternative Compensation Plan for Elon Musk
  • Blade Air Mobility Sells Rideshare Business to Joby Aviation for $125 Million
  • Qualcomm Posts Strong Q3 Results, Fueled by Automotive and IoT Growth

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

Hims & Hers Shares Dip Despite Strong Growth as Revenue Misses Forecast

August 5, 2025
trading-chart-2

Palantir Surges Past $1 Billion Quarterly Revenue, Lifts Guidance Amid AI Boom

August 4, 2025
tesla

Tesla Board Approves $29 Billion Alternative Compensation Plan for Elon Musk

August 4, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?